Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3,Randomized,Double-blind,Placebo-controlled Study to Evaluate the Clinical Performance and Safety of an Intra-articular Solution of High and Low Molecular Weight Hyaluronic Acid (HL-01) in the Treatment of Pain in Symptomatic Knee Osteoarthritis

NCT03200288 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.

NCT NCT03200288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03200288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3,Randomized,Double-blind,Placebo-controlled Study to Evaluate the Clinical Performance and Safety of an Intra-articular Solution of High and Low Molecular Weight Hyaluronic Acid (HL-01) in the Treatment of Pain in Symptomatic Knee Osteoarthritis
Lead sponsor
IBSA Institut Biochimique SA
Phase
Phase 3
Overall status
Completed
Start date
June 29, 2017
Completion date
October 30, 2018
Enrollment
692 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis